Tissue analysis for thiazide diuretics.

R A Merriken

Home/Archive/PubMed

PubMed · 7417191

Tissue analysis for thiazide diuretics.

R A Merriken

View original source ↗Export metadata ↓

Abstract

With the advent of liquid chromatography, identification and quantitation of thiazides by use of milder, non-destructive techniques will be at our disposal. Alternative methods, however, are available. The scheme of analysis presented here--i.e. initial screening with a sensitive but nonspecific colorimetric technique, identification and confirmation with thin-layer chromatography and gas chromatography, and quantitation by gas chromatographic techniques--is a realistic approach to the analysis of diuretics in tissue.

Explore related subjects

Benzothiadiazines Chromatography, Gas Chromatography, Thin Layer Colorimetry Diuretics Humans Liver Sodium Chloride Symporter Inhibitors Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R A Merriken. 1980. Tissue analysis for thiazide diuretics.. https://pubmed.ncbi.nlm.nih.gov/7417191/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Medical management of nephrolithiasis.

About 1 out of 14 males and 1 out of 30 females are afflicted with kidney stones. In many of these patients, the disease is recurrent. Fortunately, our understanding of the disease and ability to treat renal stone disease has increased in the last decade. Parenteral NSAIDs have been shown to be as effective as narcotics in treating renal colic. Dietary and drug therapy after proper metabolic evaluation of patients with recurrent stones is beneficial in reducing the recurrence rate. New understanding of the role of diet and many organic inhibitors of crystallization in urine will further broaden the scope of management of this common disease.

Benzothiadiazines↗

PubMed1997

Southwestern Internal Medicine Conference: medical management of nephrolithiasis--a new, simplified approach for general practice.

Considerable progress has been made regarding pathophysiology, diagnosis, and medical prevention of recurrent renal stone formation. The medical approach is not applied widely because of the availability of extracorporeal shockwave lithotripsy and the complexity of medical diagnostic and treatment modalities. In this review, a simplified program for the medical management of stones is described. From analysis of stone risk factors in 24-hour urine specimens, uncomplicated calcium stone disease is separated from other stone diseases. The uncomplicated calcium stone disease, comprising the illness in the majority of patients with recurrent renal calculi, is characterized by normocalcemia, normouricemia, calcium stones, and the absence of urinary tract infection, bowel disease, or marked hyperoxaluria. Uncomplicated calcium stone disease is separated into a hypercalciuric group and a normocalciuric group. In the simplified treatment program, the hypercalciuric group would be offered thiazide plus potassium citrate, whereas the normocalciuric group would receive potassium citrate alone.

Benzothiadiazines↗

PubMed1996

The evolution of low-dose diuretic therapy: the lessons from clinical trials.

Safe and effective antihypertensive therapy became available in the 1950s with the introduction of thiazide diuretics. Prior to that time, we did have agents that lowered blood pressure but they often needed to be given parenterally and were too poorly tolerated to be used for the treatment of any but those with life-threatening elevations of blood pressure. When thiazide diuretics-first chlorothiazide and then hydrochlorothiazide-became available, it was possible to lower blood pressure in most hypertensives and assess whether that reduction would lead to a reduction in cardiovascular morbidity and mortality. The results of 17 large trials have now made it clear that antihypertensive therapy with regimens based on diuretics and beta blockers reduces cardiovascular events and saves lives. When first introduced, thiazide diuretics were prescribed at doses we now know are excessively high (100-200 mg of hydrochlorothiazide/day), and we have learned that much lower doses, even as little as 12.5 mg of hydrochlorothiazide, are effective. These lower doses will reduce blood pressure and do so with considerably less in the way of metabolic effects. This article will trace the development of antihypertensive therapy and review how data from clinical trials have influenced the recommendations of the Joint National Committees on the Detection, Evaluation and Treatment of Hypertension.

Benzothiadiazines↗